Skip to content

T2 (NASDAQ: TTOO), founded in 2006, is a medical diagnostics company focused on the development and commercialization of innovative products designed to improve patient care and reduce the cost of care by helping clinicians effectively treat patients faster than ever before. T2’s products include the T2Dx® Instrument, T2Candida® Panel, and T2Bacteria® Panel. The company also has a strong pipeline of products for sepsis management, including bacterial resistance panels and a Lyme disease panel.

Latest News from T2 Biosystems